HLA-A and melanoma: NOD-SCIDβ2m-/- mice were reconstituted intra-peritoneally with human HLA-A*0201+ PBMC and weekly vaccinated subcutaneously with irradiated peptide-pulsed GEN cells before or after being challenged with melanoma tumor cells.